Nanodiagnostics will be a $50-billion Market by 2021

Share Article

Cientifica's Nanotechnology for Medical Diagnostics looks at emerging nanoscale technologies.

The healthcare market, poised to see some of the earliest benefits of nanotechnology over the next decade, will be one of nanotech's highest growth sectors. Technology is advancing on all fronts, from highly affordable point-of-care diagnostics with the potential to make mass screening and early detection of disease possible, through to highly targeted therapeutics with drugs being delivered and released only where needed.

Nanotechnology promises to revolutionize medical diagnostics: earlier detection of disease, higher sensitivity, higher accuracy, higher throughput capability, more results per assay; time saving and cost-effectiveness.

“The implications are enormous,” said Tim Harper, CEO of Cientifica Ltd. “Diagnostic tools using nanotechnology are pushing the envelope in terms of speed, sensitivity and cost and are beginning to have an impact on almost every sector. In 10 years' time the idea of taking a blood sample and sending it away to be analyzed will be seem as old fashioned as buying music from a 'record' store.”

Following on from Cientifica’s Nanotechnology for Drug Delivery report series (, Nanotechnology for Medical Diagnostics ), a 237-page report, takes a comprehensive look at current and emerging nanoscale technologies used for medical diagnostics. Areas examined include quantum dots, gold nanoparticles, exosomes, nanoporous silica, nanowires, micro- and nanocantilever arrays, carbon nanotubes, ion channel switch nanobiosensors, and many more.

Cientifica estimates medical imaging is the sector showing the highest growth and impact of nanomaterials. Already a $1.7-billion market, with gold nanoparticle applications accounting for $959 million, imaging will continue to be the largest nanodiagnostics sector, with gold nanoparticles, quantum dots and nanobiosensors all easily exceeding $10 billion.
“Getting onboard with the right technology at the right time is crucial,” said Harper. “The use of exosomes in diagnosis, for instance, a relatively new technique and a tiny market, is set to reach close to half a billion dollars by 2021.”
The report is available at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tim Harper

Email >
Visit website